Treatment of Allergic Conjunctivitis in Children
Dual-action topical antihistamine/mast cell stabilizers are the first-line treatment for allergic conjunctivitis in children, with olopatadine being FDA-approved for children as young as 2 years of age. 1, 2
Step-wise Treatment Approach
First-line Treatment
- Topical dual-action antihistamine/mast cell stabilizers:
- Olopatadine 0.1-0.2% (FDA approved for children ≥2 years): One drop in affected eye(s) once daily 1, 2
- Other options: epinastine, ketotifen, azelastine 1, 3
- These medications provide both immediate symptom relief and prevention of symptoms with onset within 30 minutes 1
- More effective than single-action medications and have better local tolerability in children 4, 3
Non-pharmacological Interventions (Use alongside medications)
- Allergen avoidance: Identify and minimize exposure to potential allergens 1
- Cold compresses: Reduce local pain and swelling 1
- Preservative-free artificial tears: Dilute allergens and inflammatory mediators on the ocular surface 5, 1
- Environmental modifications:
- Humidify ambient air to prevent tear evaporation
- Avoid direct air drafts (fans, air conditioning) 1
Second-line Treatment (For moderate to severe symptoms)
- Short-term topical corticosteroids (1-2 weeks):
Third-line Treatment (For severe or refractory cases)
- Topical cyclosporine: For long-term management of severe cases 5, 1, 8
- Topical tacrolimus: Effective for severe allergic conjunctivitis 5, 1
Special Considerations for Children
- Age restrictions: Olopatadine is FDA approved for children 2 years and older; consult a doctor for children under 2 years 2
- Follow-up: Schedule follow-up within 1-2 weeks when initiating corticosteroid therapy 1
- Contact lens wearers: Remove lenses before instilling drops and wait at least 5 minutes before reinsertion 1
- Monitoring: Regular follow-up visits should include interval history, visual acuity measurement, and slit-lamp biomicroscopy 5
When to Refer to an Ophthalmologist
Refer children with allergic conjunctivitis to an ophthalmologist in the following circumstances:
- Visual loss
- Moderate or severe pain
- Severe purulent discharge
- Corneal involvement
- Lack of response to therapy
- Recurrent episodes
- Suspected vernal keratoconjunctivitis or atopic keratoconjunctivitis 5, 1, 8
Cautions and Pitfalls
- Avoid prolonged use of ocular decongestants/vasoconstrictors (>10 days) as they can cause rebound hyperemia ("conjunctivitis medicamentosa") 1
- Oral antihistamines may induce or worsen dry eye syndrome and impair the tear film's protective barrier 5, 1
- Avoid punctal plugs as they prevent flushing of allergens and inflammatory mediators from the ocular surface 1
- Do not use steroid eye drops without ophthalmologist supervision 1
- Avoid tap water for irrigation if you suspect a corneal abrasion 1
Ketotifen fumarate 0.025% has been specifically studied in pediatric populations (ages 8-16) and shown to be effective and safe with no drug-related systemic adverse events reported 9, making it another good option for children with allergic conjunctivitis.